www.bioscience.co.uk
Sales & Support: +44 (0)1223 316 855

*

Oritavancin diphosphate

Supplier:
Catalogue number:
B2713-5
Size:
5 mg
Product is available in:
  • UK
  • Ireland
  • Europe
  • USA
  • Rest of World
£147.00 Estimated delivery Wed 23 Jun
Shipping is calculated in checkout

Oritavancin diphosphate is a second-generation, semi-synthetic lipoglycopeptide, that is derived from chloroeremomycin, an analogue of vancomycin. Similar to vancomycin, it contains a core heptapeptide, however, its unique lipophilic side chain provides oritavancin with a prolonged half-life compared to the parent drug. Oritavancin has a multifaceted mechanism of action that displays concentration-dependent effects against gram-positive organisms. Similar to vancomcyin and other glycopeptides, oritavancin inhibits cell wall biosynthesis by binding noncovalently to the D-alanyl-D-alanine terminal ends of the peptidoglycan chain and pentaglycine bridge, thereby inhibiting transglycosylation and transpeptidation.

Product Type:

Biochemicals

CAS Number:

192564-14-0

Storage Temp:

-20°C

Compound Purity:

≥98% by HPLC

Molecular Weight:

1989.09

UNSPSC Code:

12352200

Oritavancin diphosphate

Oritavancin diphosphate

Details Cat number & supplier Size Price
Oritavancin diphosphate B2713-25 · BioVision
B2713-25
BioVision
25 mg £581.00
25 mg
view
AMZ30 B2714-25 · BioVision
B2714-25
BioVision
25 mg £581.00
25 mg
view
Clofazimine B2712-50 · BioVision
B2712-50
BioVision
50 mg £83.00
50 mg
view
AMZ30 B2714-5 · BioVision
B2714-5
BioVision
5 mg £147.00
5 mg
view
Clofazimine B2712-250 · BioVision
B2712-250
BioVision
250 mg £249.00
250 mg
view
N6-Methyladenosine B2715-250 · BioVision
B2715-250
BioVision
250 mg £249.00
250 mg
view
ML-210 B2710-5 · BioVision
B2710-5
BioVision
5 mg £147.00
5 mg
view